Ms Eil?sh Hardiman:

That is our reporting line for elements like that. If I may, the Boston review was not sold by us as an independent review. That is important. It was external to us; they were to come in and look at clinical elements. We were concerned around the clinical elements, which was the focus. What the HSE is doing is independent. It is a different type of review. I wish to clarify that.